Personalis, Inc. (NASDAQ:PSNL) Stock Position Reduced by Stifel Financial Corp

Stifel Financial Corp decreased its position in Personalis, Inc. (NASDAQ:PSNL) by 33.3% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 20,000 shares of the company’s stock after selling 10,000 shares during the quarter. Stifel Financial Corp’s holdings in Personalis were worth $108,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in PSNL. Acadian Asset Management LLC increased its stake in Personalis by 6.7% during the second quarter. Acadian Asset Management LLC now owns 1,057,956 shares of the company’s stock valued at $1,237,000 after purchasing an additional 66,128 shares during the last quarter. IQ EQ FUND MANAGEMENT IRELAND Ltd grew its position in shares of Personalis by 42.5% during the 3rd quarter. IQ EQ FUND MANAGEMENT IRELAND Ltd now owns 15,103 shares of the company’s stock valued at $81,000 after buying an additional 4,504 shares during the last quarter. nVerses Capital LLC acquired a new stake in Personalis during the third quarter worth about $40,000. International Assets Investment Management LLC lifted its holdings in Personalis by 438.0% in the third quarter. International Assets Investment Management LLC now owns 20,982 shares of the company’s stock worth $113,000 after acquiring an additional 17,082 shares during the last quarter. Finally, Semanteon Capital Management LP bought a new position in Personalis in the third quarter worth about $375,000. 61.91% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on the company. HC Wainwright increased their price target on Personalis from $9.00 to $11.00 and gave the stock a “buy” rating in a research report on Friday, December 20th. Needham & Company LLC restated a “buy” rating and set a $7.25 price objective on shares of Personalis in a research note on Friday, December 20th.

Personalis Stock Up 1.7 %

Personalis stock opened at $5.97 on Tuesday. Personalis, Inc. has a 52-week low of $1.12 and a 52-week high of $7.20. The firm has a market capitalization of $421.77 million, a price-to-earnings ratio of -3.55 and a beta of 1.88. The firm has a 50-day moving average price of $4.50 and a two-hundred day moving average price of $4.08.

Personalis (NASDAQ:PSNL) last issued its quarterly earnings data on Wednesday, November 6th. The company reported ($0.64) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.33) by ($0.31). Personalis had a negative return on equity of 66.07% and a negative net margin of 104.52%. The business had revenue of $25.71 million for the quarter, compared to analyst estimates of $20.67 million. During the same quarter in the prior year, the firm posted ($0.51) earnings per share. Research analysts expect that Personalis, Inc. will post -1.41 earnings per share for the current year.

About Personalis

Personalis, Inc develops and markets advanced cancer genomic tests and analytics primarily in the United States, Europe, and the Asia-Pacific. Its tests and analytics are used by pharmaceutical companies for translational research, biomarker discovery, and development of personalized cancer therapies, as well as advanced tests are used by physicians to detect cancer recurrence, monitor cancer evolution, and uncover insights for therapy selection.